GlassScriptPhysician profile
Gala Markia Barden
NPI 1578874749
$8,193.88
in general payments reported to CMS, 2019-2025
27 companies · $6,534 in 2025
The $6,534 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $72.94 · 2021: $93.75 · 2022: $538 · 2023: $360 · 2024: $196 · 2025: $6,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,157 · Food and Beverage: $1,486 · Travel and Lodging: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,157.28 |
| Food and Beverage | $1,486.11 |
| Travel and Lodging | $1,446.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,382.01 | 2019-2025 | |
| Medtronic, INC. | $248.32 | 2022-2025 | Ligasure, Sonicision |
| Takeda Pharmaceuticals U.S.A., INC. | $241.75 | 2023-2025 | Gattex, Eohilia |
| Kerecis Limited | $205.77 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $135.50 | 2019-2022 | |
| Abbvie INC. | $104.93 | 2021-2023 | Dalvance |
| Smith+Nephew, INC. | $98.36 | 2023-2025 | Collagenase Santyl, Oasis Micro, Renasys Go V2 Home |
| Csl Behring | $84.83 | 2021-2023 | Kcentra |
| Solventum Corporation | $80.70 | 2025 | Activ.A.C., Abthera, Prevena |
| Acera Surgical, INC. | $77.00 | 2019-2023 | Restrata Wound Matrix |
| Misonix INC | $57.39 | 2019 | |
| Avanos Medical | $49.18 | 2019 | |
| W. L. Gore & Associates, INC. | $44.27 | 2020-2025 | Gore Synecor Biomaterial |
| Cumberland Pharmaceuticals, INC. | $41.85 | 2019 | |
| Tela Bio, INC. | $39.16 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $34.91 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $32.79 | 2019 | |
| Allergan, INC. | $29.84 | 2019-2020 | |
| Teleflex LLC | $27.78 | 2019 | |
| Portola Pharmaceuticals, LLC | $27.04 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $25.41 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.60 | 2023 | Exparel |
| Davol INC. | $21.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.93 | 2023 | Andexxa |
| Alexion Pharmaceuticals, INC. | $20.97 | 2022 | |
| Boston Scientific Corporation | $17.94 | 2019 | |
| Convatec INC. | $17.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gala Barden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.